These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 9918241

  • 21. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM, Marx AS, Barry NN.
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Kinoshita M.
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [Abstract] [Full Text] [Related]

  • 32. Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.
    Miret C, Font J, Molina R, Filella X, Vivancos J, Muñoz-Rodriguez FJ, Cervera R, Ballesta AM, Ingelmo M.
    Anticancer Res; 1998 Dec; 18(2B):1341-4. PubMed ID: 9615813
    [Abstract] [Full Text] [Related]

  • 33. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 34. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P.
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [Abstract] [Full Text] [Related]

  • 35. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity.
    Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D.
    J Rheumatol; 2000 Jul; 27(7):1681-5. PubMed ID: 10914851
    [Abstract] [Full Text] [Related]

  • 36. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
    Tso TK, Huang WN.
    J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
    [Abstract] [Full Text] [Related]

  • 37. Elevated soluble fas production in SLE correlates with HLA status not with disease activity.
    Rose LM, Latchman DS, Isenberg DA.
    Lupus; 1997 Apr; 6(9):717-22. PubMed ID: 9412987
    [Abstract] [Full Text] [Related]

  • 38. Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.
    Ugurel S, Rappl G, Tilgen W, Reinhold U.
    Clin Cancer Res; 2001 May; 7(5):1282-6. PubMed ID: 11350895
    [Abstract] [Full Text] [Related]

  • 39. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
    van Vollenhoven RF, Bieber MM, Powell MJ, Gupta PK, Bhat NM, Richards KL, Albano SA, Teng NN.
    J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
    [Abstract] [Full Text] [Related]

  • 40. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M.
    Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.